Primary Site >> Colorectal Cancer

Gene >> TAB2

  • 2006
  • 2011
  • 2013
Ref: Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT).
PMID: 16536473
 Ref: RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.
PMID: 21834757
 Ref: Gemifloxacin, a fluoroquinolone antimicrobial drug, inhibits migration and invasion of human colon cancer cells.
PMID: 24386633